HCRN Directory

Liver and Bile Duct

HCRN-GI15-225

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma With Preserved Liver Function. HCRN: GI15-225

Status

Closed

Cancer Types

Liver and Bile Duct

Locations

HCRN-GI16-263

A phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma with pembrolizumab and Sylatron (peginterferon alfa-2b) HCRN GI16-263

Status

Closed

Cancer Types

Liver and Bile Duct

Locations

HCRN-GI19-405

A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y-90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC)

Status

Closed

Cancer Types

Liver and Bile Duct

Locations

BTCRC-GI13-002

An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients With Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI13-002

Status

Closed

Cancer Types

Liver and Bile Duct

Locations

BTCRC-GI20-457

A Phase II study of Atezolizumab and Bevacizumab in Child-Pugh B7 Hepatocellular Carcinoma (The AB7 Trial) Big Ten Cancer Research Consortium BTCRC-GI20-457

Status

Open to Accrual

Cancer Types

Liver and Bile Duct

Locations

DHR Health, Fred & Pamela Buffett Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, New York University Cancer Institute, Rutgers Cancer Institute of New Jersey, University of Illinois Cancer Center, University of Wisconsin Carbone Cancer Center

GI06-101

Phase II Trial of Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas: Hoosier Oncology Group GI06-101

Status

Closed

Cancer Types

Liver and Bile Duct

Locations